Sarissa Capital Management as of March 31, 2026
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 9 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Innoviva (INVA) | 31.5 | $50M | 2.1M | 23.30 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 20.5 | $32M | 9.2M | 3.51 | |
| Amarin Corp Sponsored Adr (AMRN) | 15.4 | $24M | 1.7M | 14.46 | |
| Neurocrine Biosciences (NBIX) | 9.7 | $15M | 117k | 131.74 | |
| Cytokinetics Com New (CYTK) | 9.6 | $15M | 229k | 65.91 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 8.0 | $13M | 167k | 75.85 | |
| Biohaven (BHVN) | 3.0 | $4.8M | 563k | 8.46 | |
| Regeneron Pharmaceuticals (REGN) | 2.1 | $3.2M | 4.2k | 772.64 | |
| Vor Biopharma Com New (VOR) | 0.3 | $453k | 25k | 17.84 |
